| Synonyms: | |
| Status: | Approved (1981) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N06AX05 |
| UNII: | YBK48BXK30 |
| InChI Key | PHLBKPHSAVXXEF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H22ClN5O |
| Molecular Weight | 371.87 |
| AlogP | 2.36 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 45.78 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 26.0 |
| Primary Target | |
|---|---|
| 5-HT2A receptor | |
| 5-HT2C receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 4 | D003866 | ClinicalTrials |
| Anxiety | 3 | D001007 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Dementia | 3 | D003704 | ClinicalTrials |
| Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
| Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
| Sleep Initiation and Maintenance Disorders | 3 | D007319 | ClinicalTrials |
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Sleep Apnea, Obstructive | 1 | D020181 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 19794-93-5 |
| ChEBI | 9654 |
| ChEMBL | CHEMBL621 |
| DrugBank | DB00656 |
| DrugCentral | 2717 |
| EPA CompTox | DTXSID5045043 |
| FDA SRS | YBK48BXK30 |
| Human Metabolome Database | HMDB0014794 |
| Guide to Pharmacology | 213 |
| KEGG | C07156 |
| PharmGKB | PA451744 |
| PubChem | 5533 |
| SureChEMBL | SCHEMBL28167 |
| ZINC | ZINC000000538483 |